RXR Activation: Hope for New Parkinson’s Disease Treatment

December 17, 2009

Following up on their previous work showing the rescue of dopamine neurons by chemicals that interact with the retinoid X receptor (RXR), researchers have now investigated the potential of these chemicals, known as RXR ligands, for the treatment of Parkinson’s disease. Writing in the open access journal BMC Neuroscience the scientists describe the use of two cellular models of Parkinsonian damage to explore the neuroprotective function of the two RXR ligands LG268 and XCT.

To read the full story, please click the following link:

http://www.sciencedaily.com/releases/2009/12/091210193158.htm

Advertisements

One Response to “RXR Activation: Hope for New Parkinson’s Disease Treatment”

  1. Rich: Very Hopeful! I was encouraged as my Dad was a PD patient.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: